Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

SCFD2 Activators

SCFD2 activators belong to a niche category of chemical agents that specifically target the SCFD2, which is shorthand for a component within cellular machinery. The exact nature of SCFD2 remains a topic of scientific research, but it is understood to play a role in a variety of cellular processes. Activators of this component are compounds that can bind to or interact with SCFD2, thereby modulating its activity. The chemical structure of these activators can be diverse, reflecting the specificity and complexity of the biological pathways they are involved with. These molecules can be designed to have high affinity and selectivity for SCFD2, ensuring that their activity is as targeted as possible. Their interaction with SCFD2 can induce a conformational change in the protein, which in turn can have downstream effects on the function of the protein, potentially affecting various intracellular signaling pathways and cellular functions.

The study of SCFD2 activators is an intricate field that combines elements of biochemistry, molecular biology, and chemistry. Researchers in this area work to understand the precise molecular interactions between these activators and SCFD2, including the binding kinetics and dynamics. This involves detailed characterizations using techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling to visualize and predict the binding modes and affinity of these molecules. The role of SCFD2 in cellular processes means that activators can be influential in modulating the intrinsic activity of the protein, which in turn can affect the overall state of the cell. This modulation is highly specific and relies on the precise structure-activity relationship (SAR) inherent in the chemical makeup of the activators. The development and study of SCFD2 activators are thus grounded in deepening the understanding of protein-ligand interactions and the subtle nuances of protein regulation within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin modulates intracellular cAMP levels, which can indirectly enhance the activity of SCFD2 by promoting protein-protein interactions required for its scaffolding functions.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased cAMP levels. Elevated cAMP could enhance SCFD2's role in vesicular trafficking by stabilizing the protein complexes involved.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

This polyphenol inhibits kinases that may be competing with signaling pathways that SCFD2 is involved in, thereby potentially enhancing SCFD2's functional activity in membrane fusion events.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

As a PDE5 inhibitor, Zaprinast increases cGMP levels which may augment SCFD2's activity in vesicular transport through the cGMP-dependent signaling pathways.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits PDE4, leading to an increase in cAMP levels. This could indirectly activate SCFD2 by fostering an environment conducive to its role in the secretory pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 inhibits Rho-associated protein kinase (ROCK), which may enhance the activity of SCFD2 through modulation of the actin cytoskeleton, thus influencing vesicular trafficking.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

Blebbistatin is a myosin II inhibitor. By altering cytoskeletal dynamics, it may indirectly enhance SCFD2's role in vesicular transport and cargo delivery.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

ML-7 is an inhibitor of myosin light-chain kinase (MLCK). Its inhibition could create favorable conditions for SCFD2-mediated vesicular trafficking by reducing cytoskeletal tension.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 could indirectly enhance SCFD2's activity in the secretory pathway by modifying vesicular docking and fusion processes.

Calmidazolium chloride

57265-65-3sc-201494
sc-201494A
10 mg
50 mg
$156.00
$612.00
27
(1)

Calmidazolium chloride is a calmodulin antagonist. It may enhance SCFD2's function by affecting calcium-mediated signaling pathways involved in vesicular trafficking and fusion events that SCFD2 may facilitate.